No safe level of smoking exists for heart disease and stroke

If you think smoking only one or two cigarettes a day is almost harmless, think again. Professor Allan Hackshaw at the Cancer Institute, University College London and colleagues examined the risk of stroke and heart disease associated with light smoking (one to five cigarettes per day). Their large-scale systematic review provides a major body of evidence highlighting the importance of […]

Read More…

Mending broken hearts: The American Heart Association and its life-saving treatment guidelines

american heart association research outreach

When someone suffers a cardiac arrest, the first few minutes that follow the attack are crucial and can decide if someone lives or dies. The effective administration of cardiopulmonary resuscitation (CPR) can greatly improve people’s chances. The American Heart Association have been educating people on CPR, heart health, stroke and heart disease worldwide for nearly 100 years and their latest mission […]

Read More…

High pressure talk with Professor Rhian Touyz

At the Institute of Cardiovascular and Medical Science (ICAMS) at the University of Glasgow, world-renowned researchers are dedicated to discovering mechanisms of cardiovascular disease (CVD) in their quest to advance new treatments and to develop improved prevention, management and diagnostic strategies. Professor Rhian Touyz takes an innovative new approach to preventing CVD by conducting extensive research into other intricately linked […]

Read More…

Extending the half‑life of therapeutic peptides

This article is about Dr Alhamadsheh’s research which combines synthetic organic chemistry with biochemistry and molecular biology to study protein-protein interactions.

Dr Mamoun Alhamadsheh is Associate Professor at the University of the Pacific, Thomas J. Long School of Pharmacy and Health Sciences, California. He heads a multi-disciplinary team working in the field of protein-protein interactions. Their research is focused on the development of new treatments for diseases caused by protein aggregation, including Alzheimer’s disease and transthyretin amyloidosis. Their current work in […]

Read More…

Expanding capacity of non-communicable disease research and training in Thailand

Dr Kathleen Potempa’s research program has focused on fatigue, exercise, and cardiovascular fitness in physically impaired populations.

Dr Kathleen Potempa is Professor at the School of Nursing in the University of Michigan, where she served as Dean from 2006 to 2016. A globally renowned leader in nursing, education and science, she has a long academic career focusing on cardiovascular fitness in physically impaired populations, nursing, leadership, and community-based approaches to improving health. She is currently collaborating with […]

Read More…

Preventing and treating complications of heart failure and Fabry disease

Dr Gavin Y Oudit, a distinguished cardiologist from the University of Alberta, focuses his research on developing ground-breaking therapies to treat both genetic and non-genetic cardiovascular disorders, and to prevent heart failure. His exciting work into the role of ACE2 has provided a fundamental scientific understanding used in the development of therapeutic options for cardiovascular, renal and lung diseases. He […]

Read More…